Author

M. Arditi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Assay:proteomics· 3 Approach:experimental assay· 2 Assay:CITE-seq· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:statistical model· 1

Frequent Co-Authors

I. Bahar· 3 shared M. H. Cheng· 3 shared R. A. Porritt· 3 shared M. Noval Rivas· 2 shared A. B. Ozdemir· 1 shared A. Fasano· 1 shared B. C. Fries· 1 shared B. S. Franklin· 1 shared

Activity by Year

2019-2020 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

I. Bahar

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

A monoclonal antibody against staphylococcal enterotoxin B superantigen inhibits SARS-CoV-2 entry in vitro

M. H. Cheng, R. A. Porritt, M. Noval Rivas, J. Krieger, A. B. Ozdemir, G. Garcia, V. Arumugaswami, B. C. Fries, M. Arditi, I. Bahar

This paper shows that an anti-SEB monoclonal antibody inhibits SARS-CoV-2 entry by blocking protease access to the Spike protein's cleavage site.

bioRxiv · Nov 24, 2020Immunology

Identification of a unique TCR repertoire, consistent with a superantigen selection process in Children with Multi-system Inflammatory Syndrome

R. A. Porritt, L. Paschold, M. Noval Rivas, M. H. Cheng, L. M. Yonker, H. Chandnani, M. Lopez, D. Simnica, C. Schultheiss, C. Santiskulvong, J. Van Eyk, A. Fasano, I. Bahar, M. Binder, M. Arditi

This study identifies a skewed TCR repertoire in MIS-C patients, with TRBV11-2 expansion linked to disease severity and superantigen-like interactions with SARS-CoV-2 spike protein.

bioRxiv · Nov 9, 2020 · PreprintImmunology

An insertion unique to SARS-CoV-2 exhibits superantigenic character strengthened by recent mutations

M. H. Cheng, S. Zhang, R. A. Porritt, M. Arditi, I. Bahar

The paper identifies a SARS-CoV-2 spike protein motif with superantigen-like properties that may contribute to MIS-C and cytokine storms in COVID-19 patients.

bioRxiv · May 21, 2020Immunology

Platelets fuel the inflammasome activation of innate immune cells

V. Rolfes, L. S. Ribeiro, I. Hawwari, L. Buotcher, N. S. Rosero, S. Maasewerd, M. L. S. Santos, S. V. Schmidt, M. Rothe, J. Stunden, L. H. Carvalho, C. J. Fontes, T. Prochnicki, M. Arditi, E. Latz, B. S. Franklin

This study shows platelets enhance inflammasome activation in immune cells, increasing IL-1β production, and identifies a platelet gene signature linked to autoinflammatory diseases.

bioRxiv · Oct 11, 2019Immunology